Salzhauer Michael’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Salzhauer Michael’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-497,897	Closed	-$174K	–	178
2018 Q2	$174K	Buy	497,897 +277,744	+126%	+$228K	0.06%	153
2018 Q1	$330K	Buy	220,153 +113,860	+107%	+$199K	0.12%	112
2017 Q4	$151K	Hold	106,293	–	–	0.06%	149
2017 Q3	$243K	Hold	106,293	–	–	0.1%	130
2017 Q2	$144K	Buy	106,293 +4,600	+5%	+$6.64K	0.07%	147
2017 Q1	$216K	Buy	+101,693	New	+$382K	0.1%	131

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Salzhauer Michael's ARLZ Position: Q3 2018 in Review

Salzhauer Michael sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 497,897 shares — an estimated $174K sold.

Salzhauer Michael first reported a position in ARLZ in Q1 2017 and held it in 6 quarters. The position peaked at $330K in Q1 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Salzhauer Michael reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Salzhauer Michael sold 497,897 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $174K.
Salzhauer Michael first reported a position in Aralez Pharmaceuticals Inc. in Q1 2017 and held it in 6 quarters.
Salzhauer Michael's Aralez Pharmaceuticals Inc. position peaked at $330K in Q1 2018.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Salzhauer Michael's 13F filing for Q3 2018, filed 1 Nov 2018.